Apollo’s Covis sues over preterm-birth drug patents
05-01-2021
Supermarket chain settles pay-for-delay suit over birth control pill
19-12-2019
Allergan pays $750m to resolve antitrust litigation
29-10-2019
Pavel Kapysh / Shutterstock.com
Allergan’s Warner Chilcott and Watson subsidiaries have agreed to pay $300 million to end antitrust litigation centering on contraceptive pills Loestrin 24 Fe and Minastrin 24 Fe.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Allergan, Warner Chilcott, Watson, contraceptives, antitrust litigation, pay-for-delay, generics
